Cyclacel Pharmaceuticals Inc (CYCC)
1.51
-0.09
(-5.62%)
USD |
NASDAQ |
Apr 26, 16:00
1.51
0.00 (0.00%)
After-Hours: 20:00
Cyclacel Pharmaceuticals 1 Year Total Returns (Daily): -83.25% for April 26, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
April 26, 2024 | -83.25% |
April 25, 2024 | -82.52% |
April 24, 2024 | -75.85% |
April 23, 2024 | -81.67% |
April 22, 2024 | -82.08% |
April 19, 2024 | -82.55% |
April 18, 2024 | -81.31% |
April 17, 2024 | -77.79% |
April 16, 2024 | -80.61% |
April 15, 2024 | -81.77% |
April 12, 2024 | -79.92% |
April 11, 2024 | -78.80% |
April 10, 2024 | -77.43% |
April 09, 2024 | -76.27% |
April 08, 2024 | -76.27% |
April 05, 2024 | -75.46% |
April 04, 2024 | -74.36% |
April 03, 2024 | -74.39% |
April 02, 2024 | -75.23% |
April 01, 2024 | -76.04% |
March 28, 2024 | -75.32% |
March 27, 2024 | -77.29% |
March 26, 2024 | -78.65% |
March 25, 2024 | -76.21% |
March 22, 2024 | -74.00% |
Date | Value |
---|---|
March 21, 2024 | -75.78% |
March 20, 2024 | -75.01% |
March 19, 2024 | -75.97% |
March 18, 2024 | -74.33% |
March 15, 2024 | -73.68% |
March 14, 2024 | -73.59% |
March 13, 2024 | -72.86% |
March 12, 2024 | -74.67% |
March 11, 2024 | -74.27% |
March 08, 2024 | -75.89% |
March 07, 2024 | -77.22% |
March 06, 2024 | -78.89% |
March 05, 2024 | -77.58% |
March 04, 2024 | -76.62% |
March 01, 2024 | -74.96% |
February 29, 2024 | -79.68% |
February 28, 2024 | -78.73% |
February 27, 2024 | -78.47% |
February 26, 2024 | -79.78% |
February 23, 2024 | -81.41% |
February 22, 2024 | -81.54% |
February 21, 2024 | -82.25% |
February 20, 2024 | -82.24% |
February 16, 2024 | -82.79% |
February 15, 2024 | -83.08% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-86.36%
Minimum
Feb 02 2024
85.68%
Maximum
May 18 2021
-47.23%
Average
-59.96%
Median
Nov 06 2020
1 Year Total Returns (Daily) Benchmarks
Corvus Pharmaceuticals Inc | 41.46% |
Oragenics Inc | -63.21% |
Relmada Therapeutics Inc | 43.98% |
Alpine Immune Sciences Inc | 795.4% |
MAIA Biotechnology Inc | 30.67% |